The Market Reports

Index

1 Benign Prostatic Hypertrophy Implant Devices Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hypertrophy Implant Devices
1.2 Benign Prostatic Hypertrophy Implant Devices Segment by Type
1.2.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Temporary
1.2.3 Long-term
1.3 Benign Prostatic Hypertrophy Implant Devices Segment by Application
1.3.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Benign Prostatic Hypertrophy Implant Devices Market Size Estimates and Forecasts
1.4.1 Global Benign Prostatic Hypertrophy Implant Devices Revenue 2016-2027
1.4.2 Global Benign Prostatic Hypertrophy Implant Devices Sales 2016-2027
1.4.3 Benign Prostatic Hypertrophy Implant Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Benign Prostatic Hypertrophy Implant Devices Market Competition by Manufacturers
2.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Benign Prostatic Hypertrophy Implant Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Benign Prostatic Hypertrophy Implant Devices Manufacturing Sites, Area Served, Product Type
2.5 Benign Prostatic Hypertrophy Implant Devices Market Competitive Situation and Trends
2.5.1 Benign Prostatic Hypertrophy Implant Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Benign Prostatic Hypertrophy Implant Devices Players Market Share by Revenue
2.5.3 Global Benign Prostatic Hypertrophy Implant Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Benign Prostatic Hypertrophy Implant Devices Retrospective Market Scenario by Region
3.1 Global Benign Prostatic Hypertrophy Implant Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Benign Prostatic Hypertrophy Implant Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.3.1 North America Benign Prostatic Hypertrophy Implant Devices Sales by Country
3.3.2 North America Benign Prostatic Hypertrophy Implant Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.4.1 Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country
3.4.2 Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Sales by Region
3.5.2 Asia Pacific Benign Prostatic Hypertrophy Implant Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.6.1 Latin America Benign Prostatic Hypertrophy Implant Devices Sales by Country
3.6.2 Latin America Benign Prostatic Hypertrophy Implant Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country
3.7.2 Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Benign Prostatic Hypertrophy Implant Devices Historic Market Analysis by Type
4.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
4.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Type (2016-2021)
4.3 Global Benign Prostatic Hypertrophy Implant Devices Price by Type (2016-2021)

5 Global Benign Prostatic Hypertrophy Implant Devices Historic Market Analysis by Application
5.1 Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
5.2 Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Application (2016-2021)
5.3 Global Benign Prostatic Hypertrophy Implant Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Olympus Medical
6.1.1 Olympus Medical Corporation Information
6.1.2 Olympus Medical Description and Business Overview
6.1.3 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.1.5 Olympus Medical Recent Developments/Updates
6.2 Butterfly Medical
6.2.1 Butterfly Medical Corporation Information
6.2.2 Butterfly Medical Description and Business Overview
6.2.3 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.2.5 Butterfly Medical Recent Developments/Updates
6.3 SRS Medical
6.3.1 SRS Medical Corporation Information
6.3.2 SRS Medical Description and Business Overview
6.3.3 SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 SRS Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.3.5 SRS Medical Recent Developments/Updates
6.4 Teleflex Interventional Urology
6.4.1 Teleflex Interventional Urology Corporation Information
6.4.2 Teleflex Interventional Urology Description and Business Overview
6.4.3 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.4.5 Teleflex Interventional Urology Recent Developments/Updates
6.5 Urotronic
6.5.1 Urotronic Corporation Information
6.5.2 Urotronic Description and Business Overview
6.5.3 Urotronic Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Urotronic Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.5.5 Urotronic Recent Developments/Updates
6.6 Zenflow
6.6.1 Zenflow Corporation Information
6.6.2 Zenflow Description and Business Overview
6.6.3 Zenflow Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Zenflow Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.6.5 Zenflow Recent Developments/Updates
6.7 ProArc Medical
6.6.1 ProArc Medical Corporation Information
6.6.2 ProArc Medical Description and Business Overview
6.6.3 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.7.5 ProArc Medical Recent Developments/Updates
6.8 Medeon Biodesign
6.8.1 Medeon Biodesign Corporation Information
6.8.2 Medeon Biodesign Description and Business Overview
6.8.3 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product Portfolio
6.8.5 Medeon Biodesign Recent Developments/Updates

7 Benign Prostatic Hypertrophy Implant Devices Manufacturing Cost Analysis
7.1 Benign Prostatic Hypertrophy Implant Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Benign Prostatic Hypertrophy Implant Devices
7.4 Benign Prostatic Hypertrophy Implant Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Benign Prostatic Hypertrophy Implant Devices Distributors List
8.3 Benign Prostatic Hypertrophy Implant Devices Customers

9 Benign Prostatic Hypertrophy Implant Devices Market Dynamics
9.1 Benign Prostatic Hypertrophy Implant Devices Industry Trends
9.2 Benign Prostatic Hypertrophy Implant Devices Growth Drivers
9.3 Benign Prostatic Hypertrophy Implant Devices Market Challenges
9.4 Benign Prostatic Hypertrophy Implant Devices Market Restraints

10 Global Market Forecast
10.1 Benign Prostatic Hypertrophy Implant Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Benign Prostatic Hypertrophy Implant Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Benign Prostatic Hypertrophy Implant Devices by Type (2022-2027)
10.2 Benign Prostatic Hypertrophy Implant Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Benign Prostatic Hypertrophy Implant Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Benign Prostatic Hypertrophy Implant Devices by Application (2022-2027)
10.3 Benign Prostatic Hypertrophy Implant Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Benign Prostatic Hypertrophy Implant Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Benign Prostatic Hypertrophy Implant Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Benign Prostatic Hypertrophy Implant Devices Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Benign Prostatic Hypertrophy Implant Devices Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Benign Prostatic Hypertrophy Implant Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Benign Prostatic Hypertrophy Implant Devices Covered in This Study
Table 5. Global Benign Prostatic Hypertrophy Implant Devices Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Benign Prostatic Hypertrophy Implant Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Benign Prostatic Hypertrophy Implant Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Benign Prostatic Hypertrophy Implant Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Benign Prostatic Hypertrophy Implant Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Benign Prostatic Hypertrophy Implant Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Benign Prostatic Hypertrophy Implant Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benign Prostatic Hypertrophy Implant Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Benign Prostatic Hypertrophy Implant Devices Sales by Region (2016-2021) & (Units)
Table 16. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2016-2021)
Table 17. Global Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 19. North America Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 20. North America Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 23. Europe Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Benign Prostatic Hypertrophy Implant Devices Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Benign Prostatic Hypertrophy Implant Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 31. Latin America Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Benign Prostatic Hypertrophy Implant Devices Sales (Units) by Type (2016-2021)
Table 39. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Type (2016-2021)
Table 40. Global Benign Prostatic Hypertrophy Implant Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Benign Prostatic Hypertrophy Implant Devices Revenue Share by Type (2016-2021)
Table 42. Global Benign Prostatic Hypertrophy Implant Devices Price (US$/Unit) by Type (2016-2021)
Table 43. Global Benign Prostatic Hypertrophy Implant Devices Sales (Units) by Application (2016-2021)
Table 44. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Application (2016-2021)
Table 45. Global Benign Prostatic Hypertrophy Implant Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Benign Prostatic Hypertrophy Implant Devices Revenue Share by Application (2016-2021)
Table 47. Global Benign Prostatic Hypertrophy Implant Devices Price (US$/Unit) by Application (2016-2021)
Table 48. Olympus Medical Corporation Information
Table 49. Olympus Medical Description and Business Overview
Table 50. Olympus Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Olympus Medical Benign Prostatic Hypertrophy Implant Devices Product
Table 52. Olympus Medical Recent Developments/Updates
Table 53. Butterfly Medical Corporation Information
Table 54. Butterfly Medical Description and Business Overview
Table 55. Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Butterfly Medical Benign Prostatic Hypertrophy Implant Devices Product
Table 57. Butterfly Medical Recent Developments/Updates
Table 58. SRS Medical Corporation Information
Table 59. SRS Medical Description and Business Overview
Table 60. SRS Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. SRS Medical Benign Prostatic Hypertrophy Implant Devices Product
Table 62. SRS Medical Recent Developments/Updates
Table 63. Teleflex Interventional Urology Corporation Information
Table 64. Teleflex Interventional Urology Description and Business Overview
Table 65. Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Teleflex Interventional Urology Benign Prostatic Hypertrophy Implant Devices Product
Table 67. Teleflex Interventional Urology Recent Developments/Updates
Table 68. Urotronic Corporation Information
Table 69. Urotronic Description and Business Overview
Table 70. Urotronic Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Urotronic Benign Prostatic Hypertrophy Implant Devices Product
Table 72. Urotronic Recent Developments/Updates
Table 73. Zenflow Corporation Information
Table 74. Zenflow Description and Business Overview
Table 75. Zenflow Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Zenflow Benign Prostatic Hypertrophy Implant Devices Product
Table 77. Zenflow Recent Developments/Updates
Table 78. ProArc Medical Corporation Information
Table 79. ProArc Medical Description and Business Overview
Table 80. ProArc Medical Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. ProArc Medical Benign Prostatic Hypertrophy Implant Devices Product
Table 82. ProArc Medical Recent Developments/Updates
Table 83. Medeon Biodesign Corporation Information
Table 84. Medeon Biodesign Description and Business Overview
Table 85. Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Sales (Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Medeon Biodesign Benign Prostatic Hypertrophy Implant Devices Product
Table 87. Medeon Biodesign Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Benign Prostatic Hypertrophy Implant Devices Distributors List
Table 91. Benign Prostatic Hypertrophy Implant Devices Customers List
Table 92. Benign Prostatic Hypertrophy Implant Devices Market Trends
Table 93. Benign Prostatic Hypertrophy Implant Devices Growth Drivers
Table 94. Benign Prostatic Hypertrophy Implant Devices Market Challenges
Table 95. Benign Prostatic Hypertrophy Implant Devices Market Restraints
Table 96. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Type (2022-2027) & (Units)
Table 97. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Application (2022-2027) & (Units)
Table 101. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Benign Prostatic Hypertrophy Implant Devices Sales Forecast by Region (2022-2027) & (Units)
Table 105. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Benign Prostatic Hypertrophy Implant Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Benign Prostatic Hypertrophy Implant Devices
Figure 2. Global Benign Prostatic Hypertrophy Implant Devices Market Share by Type in 2020 & 2027
Figure 3. Temporary Product Picture
Figure 4. Long-term Product Picture
Figure 5. Global Benign Prostatic Hypertrophy Implant Devices Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Benign Prostatic Hypertrophy Implant Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Benign Prostatic Hypertrophy Implant Devices Market Size 2016-2027 (US$ Million)
Figure 11. Global Benign Prostatic Hypertrophy Implant Devices Sales 2016-2027 (Units)
Figure 12. Global Benign Prostatic Hypertrophy Implant Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Benign Prostatic Hypertrophy Implant Devices Sales Share by Manufacturers in 2020
Figure 14. Global Benign Prostatic Hypertrophy Implant Devices Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Benign Prostatic Hypertrophy Implant Devices Players: Market Share by Revenue in 2020
Figure 16. Benign Prostatic Hypertrophy Implant Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region (2016-2021)
Figure 18. Global Benign Prostatic Hypertrophy Implant Devices Sales Market Share by Region in 2020
Figure 19. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region (2016-2021)
Figure 20. Global Benign Prostatic Hypertrophy Implant Devices Revenue Market Share by Region in 2020
Figure 21. United States Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Benign Prostatic Hypertrophy Implant Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Benign Prostatic Hypertrophy Implant Devices by Type (2016-2021)
Figure 44. Sales Market Share of Benign Prostatic Hypertrophy Implant Devices by Application (2016-2021)
Figure 45. Sales Market Share of Benign Prostatic Hypertrophy Implant Devices by Application in 2020
Figure 46. Revenue Share of Benign Prostatic Hypertrophy Implant Devices by Application (2016-2021)
Figure 47. Revenue Share of Benign Prostatic Hypertrophy Implant Devices by Application in 2020
Figure 48. Manufacturing Cost Structure of Benign Prostatic Hypertrophy Implant Devices
Figure 49. Manufacturing Process Analysis of Benign Prostatic Hypertrophy Implant Devices
Figure 50. Benign Prostatic Hypertrophy Implant Devices Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed